Ramucirumab
CAS 1231929-97-7Biologic
Overview
Ramucirumab is a monoclonal antibody used as a cancer treatment, specifically used primarily for the treatment of advanced gastric or gastro-esophageal junction adenocarcinoma. It works by inhibiting angiogenesis, blocking the VEGFR-2 receptor, thereby hindering cancer cell growth and proliferation.
Therapeutic areas
OncologyGastrointestinal disorders
Verified Supplier Partner
Do you supply Ramucirumab? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.